JD Health International, Inc. (6618) Receives a Buy from China Renaissance
I'm PortAI, I can summarize articles.
China Renaissance analyst maintained a Buy rating on JD Health International, Inc. yesterday and set a price target of HK$93.29.TipRanks Black Friday Sale Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off JD Health International, Inc. has an analyst consensus of Strong Buy, with a price target consensus of HK$75.59.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments